Objective: A mouse model for Interferon and Ribavirin-induced neutropenia was developed to provide a tool for screening agents that exert protective effect on anticancer drug-induced neutropenia. Methods: Neutropenia was induced by intraperitoneal injections of Interferon and oral administration of Ribavirin at different doses.